NCT00836056View on ClinicalTrials.gov

Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Clindamycin 300 mg capsule

1 x 300 mg

DRUG

Cleocin HCl 300 mg capsules

1 x 300 mg

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00836056 - Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter